title: [Pharmacological properties and clinical efficacy of apixaban (Eliquis(®)].
authors.forename: Nozomi
authors.initials: N
authors.lastname: Imai
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Fujii
authors.forename: Manabu
authors.initials: M
authors.lastname: Amano
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage* / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000150:complications; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D065427:Factor Xa Inhibitors; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011720:Pyrazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology*; D011728:Pyridones / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin; D013917:Thrombin